ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 3957.0 | 3301.0 | 3221.0 |
| Other income | 48.0 | 60.0 | 56.0 |
| Total income | 4005.0 | 3361.0 | 3277.0 |
| Profit before exceptional items & tax | 790.0 | 504.0 | 656.0 |
| Profit before tax | 790.0 | 504.0 | 656.0 |
| Net profit | 652.0 | 408.0 | 513.0 |
| Operating margin | 19.7% | 15.0% | 20.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +27.10% |
|---|---|
| Net profit, quarter on quarter | +59.80% |
| Revenue, year on year | +22.90% |
| Operating profit, year on year | +23.70% |
| Operating profit, quarter on quarter | +67.10% |
BSE results filing, NSE: MARICO. Figures extracted from the filing.
Marico Ltd: key numbers
- Share price
- ₹907.45
- Market cap
- ₹1,17,987 Cr
- Revenue (annual)
- ₹13,611 Cr
- Net profit (annual)
- ₹1,762 Cr
- P/E (TTM)
- 58.5×Sector 41.3×
- Promoter holding
- 58.83%-0.08% QoQ
- FII holding
- 22.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marico Ltd
All →Marico Acquisition Worth ₹35 Cr
Marico will acquire 51% of Bonorizon Consumer Ventures via primary subscription for up to Rs 35 crore in cash. Completion is expected within 90 days of signing definitive agreements.
- Value
- ₹35.00 Cr
- Execution
- Within 90 days from signing of definitive agreements
Marico Acquisition Worth ₹113.7 Cr
Marico bought a further 20% stake in Cosmix Wellness for Rs. 113.65 Crore cash. Its holding rises from 60% to 80%.
- Value
- ₹113.7 Cr
Marico Annual General Meeting
Marico seeks postal ballot approval to appoint Rohit Jawa as Independent Director from 1 January 2027 for five years. Remote e-voting ends 7 December 2026.
Marico Earnings Call Transcript: Key Takeaways
Strong Q2: revenue +13%, EBITA +27%, PAT +31%, EBITA margin 18.2%, helped by softer copra and mix. FY27 EBITDA guidance raised to mid-20s growth, while A&P spend rose 44%.
- Call
- Guides 13% growth
Marico Management Change
Marico's board appointed Mr. Rohit Jawa as Additional Independent Director for a five-year term. Shareholder approval will be sought via postal ballot.
Marico Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹3,897 Cr (+13%), EBITDA ₹709 Cr (+27%), PAT ₹550 Cr (+31%); volume-led growth with Foods and Premium Personal Care scaling.